# OnCo record paper-basu-single-dose-hpv-lancet-oncol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-basu-single-dose-hpv-lancet-oncol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-basu-single-dose-hpv-lancet-oncol-2021" ;
  schema:name "Vaccine efficacy against persistent HPV 16/18 infection at 10 years after one, two and three doses of quadrivalent HPV vaccine in girls in India"@en ;
  schema:description "Ten years after vaccination, Indian girls who had received a single dose of HPV vaccine were as well protected against the cancer-causing HPV types as those who had two or three doses, which let the world switch to one-dose programmes."@en ;
  schema:url <https://onco.cc/key-papers/paper-basu-single-dose-hpv-lancet-oncol-2021/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(21)00453-8> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(21)00453-8> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Basu P, Malvi SG, Joshi S, et al." ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/drugs/cervavac/> ;
  onco:institutions <https://onco.cc/institutions/iarc/> ;
  onco:trials <https://onco.cc/trials/iarc-india-hpv-dose-study/>, <https://onco.cc/trials/ken-she/> ;
  onco:people <https://onco.cc/people/basu-partha/>, <https://onco.cc/people/sankaranarayanan-rengaswamy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-dose-optimisation/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .